With the growth of the pharmaceutical, biotech, and medical device industries looking positive for the future, this small-cap company stands to benefit as it provides necessary services and solutions to various companies in these industries. WuXi PharmaTech (NYSE:WX) is a global contract research and development services provider. WuXi's offerings are designed to help other companies reduce the time and cost for R&D. Since R&D involves high-risk and high expenses for the company's customers, improving this process is vital to their continued success which ultimately benefits everyone's health. Investors should benefit from the company's above average growth.
The company is a result of the 2008 merger between WuXi PharmaTech, a China-based chemistry company and AppTech Laboratory Services,...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|